Hutchens Investment Management Inc lowered its stake in shares of Danaher Corporation (NYSE:DHR) by 0.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,570 shares of the conglomerate’s stock after selling 69 shares during the period. Danaher Corporation makes up about 2.0% of Hutchens Investment Management Inc’s portfolio, making the stock its 18th largest position. Hutchens Investment Management Inc’s holdings in Danaher Corporation were worth $2,272,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Bank of Montreal Can raised its position in shares of Danaher Corporation by 13.7% in the first quarter. Bank of Montreal Can now owns 559,878 shares of the conglomerate’s stock valued at $47,887,000 after buying an additional 67,349 shares during the last quarter. Private Trust Co. NA raised its position in shares of Danaher Corporation by 0.3% in the first quarter. Private Trust Co. NA now owns 19,081 shares of the conglomerate’s stock valued at $1,632,000 after buying an additional 49 shares during the last quarter. Lathrop Investment Management Corp bought a new position in shares of Danaher Corporation during the first quarter valued at approximately $216,000. Inverness Counsel LLC NY bought a new position in shares of Danaher Corporation during the first quarter valued at approximately $418,000. Finally, Alpha Windward LLC raised its position in shares of Danaher Corporation by 0.8% in the first quarter. Alpha Windward LLC now owns 2,605 shares of the conglomerate’s stock valued at $223,000 after buying an additional 21 shares during the last quarter. 76.12% of the stock is owned by institutional investors and hedge funds.

Shares of Danaher Corporation (NYSE:DHR) traded up 0.70% during midday trading on Monday, hitting $80.38. 641,797 shares of the stock were exchanged. The company has a market cap of $55.84 billion, a price-to-earnings ratio of 25.66 and a beta of 1.03. Danaher Corporation has a one year low of $75.71 and a one year high of $88.01. The firm has a 50 day moving average of $82.89 and a 200-day moving average of $84.21.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.90 EPS. Equities analysts expect that Danaher Corporation will post $3.95 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Hutchens Investment Management Inc Has $2.27 Million Position in Danaher Corporation (DHR)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.watchlistnews.com/hutchens-investment-management-inc-has-2-27-million-position-in-danaher-corporation-dhr/1487084.html.

Several brokerages recently commented on DHR. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $88.00 price objective (down from $89.00) on shares of Danaher Corporation in a research report on Friday, April 21st. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, Janney Montgomery Scott lowered shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $91.76.

In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the sale, the insider now owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders sold a total of 38,623 shares of company stock worth $3,206,426 in the last three months. Company insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.